Literature DB >> 7774891

p53 expression and DNA ploidy of cartilage lesions.

B Coughlan1, A Feliz, T Ishida, B Czerniak, H D Dorfman.   

Abstract

The aim of this study was to investigate the expression of a tumor suppressor gene (p53) in cartilage lesions of bone and its relationship to their histological grade and DNA ploidy. An immunohistochemical assay for p53 and Feulgen-stained DNA preparations was subjected to computerized image analysis. Enchondromas, synovial chondromatosis, and low grade (grade I and II) chondrosarcomas were diploid. High grade (grade III) chondrosarcomas and high grade sarcomatous components of dedifferentiated chondrosarcomas were aneuploid. Well differentiated cartilaginous components of dedifferentiated chondrosarcomas were diploid. Microscopic examination showed weak focal positivity for p53 in one of 10 enchondromas one of six examples of synovial chondromatosis, and three of four low grade (grade I and II) chondrosarcomas. All three high grade (grade III) chondrosarcomas were strongly positive for p53. The high grade sarcomatous component of all four dedifferentiated chondrosarcomas was strongly positive for p53, whereas only focal weak positivity was noted in the well differentiated cartilaginous areas. These results were confirmed by quantitative computer-assisted image analysis, which showed that high grade aneuploid cartilage tumors demonstrated strikingly higher levels of p53 than did diploid low grade malignant tumors or benign cartilage lesions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7774891     DOI: 10.1016/0046-8177(95)90166-3

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  12 in total

Review 1.  Genetic alterations in chondrosarcomas - keys to targeted therapies?

Authors:  Andre M Samuel; Jose Costa; Dieter M Lindskog
Journal:  Cell Oncol (Dordr)       Date:  2014-01-24       Impact factor: 6.730

2.  Synovial chondromatosis: the possible role of FGF 9 and FGF receptor 3 in its pathology.

Authors:  D Robinson; A Hasharoni; Z Evron; M Segal; Z Nevo
Journal:  Int J Exp Pathol       Date:  2000-06       Impact factor: 1.925

3.  Extended intralesional treatment versus resection of low-grade chondrosarcomas.

Authors:  Chad Aarons; Benjamin K Potter; Sheila C Adams; J David Pitcher; H Thomas Temple
Journal:  Clin Orthop Relat Res       Date:  2009-01-14       Impact factor: 4.176

4.  A molecular study of synovial chondromatosis.

Authors:  Narasimhan P Agaram; Lei Zhang; Brendan C Dickson; David Swanson; Yun-Shao Sung; David M Panicek; Meera Hameed; John H Healey; Cristina R Antonescu
Journal:  Genes Chromosomes Cancer       Date:  2019-10-18       Impact factor: 5.006

5.  The role of thallium-201 and pentavalent dimercaptosuccinic acid for staging cartilaginous tumours.

Authors:  Peter Fm Choong; Toshiyuki Kunisada; John Slavin; Stephen Schlicht; Rodney Hicks
Journal:  Int Semin Surg Oncol       Date:  2004-11-08

6.  Sacral chondroblastoma - a rare location, a rare pathology: A case report and review of literature.

Authors:  Bo-Wen Zheng; Hua-Qing Niu; Xiao-Bin Wang; Jing Li
Journal:  World J Clin Cases       Date:  2021-07-16       Impact factor: 1.337

7.  Establishment of novel human dedifferentiated chondrosarcoma cell line with osteoblastic differentiation.

Authors:  Naoko Kudo; Akira Ogose; Tetsuo Hotta; Hiroyuki Kawashima; Wenguang Gu; Hajime Umezu; Tsuyoshi Toyama; Naoto Endo
Journal:  Virchows Arch       Date:  2007-07-26       Impact factor: 4.535

8.  Chondrosarcoma and peroxisome proliferator-activated receptor.

Authors:  K Nishida; T Kunisada; Z N Shen; Y Kadota; K Hashizume; T Ozaki
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

9.  Chondrosarcoma of the spine: a rare case with unusual presentation.

Authors:  John Panelos; Spyridon Voulgaris; Evangelos Michos; Michael Doukas; Konstantinos Charalabopoulos; Anna Batistatou
Journal:  Diagn Pathol       Date:  2006-10-30       Impact factor: 2.644

10.  Clinical and histopathological prognostic factors in chondrosarcomas.

Authors:  S Daugaard; O Myhre-Jensen; T Schiødt; A G Jurik; J Keller; H T Mouridsen; B Lund
Journal:  Sarcoma       Date:  1997
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.